Literature DB >> 25514544

Emotional dysregulation in a child with attention-deficit/hyperactivity disorder and anxiety: psychopharmacological stategies.

Anupriya Srivastava1, Barbara Coffey.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25514544      PMCID： PMC4350004          DOI： 10.1089/cap.2014.24102

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  9 in total

1.  Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: a family risk analysis.

Authors:  J Biederman; T Spencer; A Lomedico; H Day; C R Petty; S V Faraone
Journal:  Psychol Med       Date:  2011-08-24       Impact factor: 7.723

2.  Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study.

Authors:  Thomas J Spencer; Stephen V Faraone; Craig B H Surman; Carter Petty; Allison Clarke; Holly Batchelder; Janet Wozniak; Joseph Biederman
Journal:  Postgrad Med       Date:  2011-09       Impact factor: 3.840

Review 3.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.

Authors:  Russell A Barkley
Journal:  Psychol Bull       Date:  1997-01       Impact factor: 17.737

Review 4.  An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences.

Authors:  Joel T Nigg; B J Casey
Journal:  Dev Psychopathol       Date:  2005

5.  Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.

Authors:  Esther Sobanski; Tobias Banaschewski; Philip Asherson; Jan Buitelaar; Wai Chen; Barbara Franke; Martin Holtmann; Bertram Krumm; Joseph Sergeant; Edmund Sonuga-Barke; Argyris Stringaris; Eric Taylor; Richard Anney; Richard P Ebstein; Michael Gill; Ana Miranda; Fernando Mulas; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Hans-Christoph Steinhausen; Stephen V Faraone
Journal:  J Child Psychol Psychiatry       Date:  2010-02-01       Impact factor: 8.982

Review 6.  Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.

Authors:  Amy F T Arnsten
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Raun D Melmed; Anil Patel; Keith McBurnett; Jennifer Konow; Andrew Lyne; Noreen Scherer
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

8.  An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents.

Authors:  Daniel F Connor; Damion J Grasso; Michelle D Slivinsky; Geraldine S Pearson; Alok Banga
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05       Impact factor: 2.576

Review 9.  Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review.

Authors:  Kavita Gajria; Mei Lu; Vanja Sikirica; Peter Greven; Yichen Zhong; Paige Qin; Jipan Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-22       Impact factor: 2.570
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.